| ID | 1257 |
| Name of the vaccine | DTaP-IPVmkc |
| Microbe | Bacteria |
| Disease name | Diphtheria |
| Name of bacteria | Corynebacterium diphtheriae |
| Type of vaccine | Combination |
| Nucleic acid content | DNA |
| Age | up to 49 days |
| Description of the vaccine | DTaP-IPV containing IPV produced in monkey kidney cells. |
| Name of the manufacturer | Statens Serum Institut |
| Name of the manufacturing country | Poland |
| Year of manufacture | 2006 |
| Clinical Phase status | Clinical - Phase 3 |
| Bacterial strain | Gram-positive bacillus. |
| Efficacy | NA |
| Vaccine formulation | Solution |
| Dosage | 0.5 mL at 2, 3.5, 5 and 16 months of age. |
| Mechanism of action | NA |
| Route of administration | Intramuscular |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | For tetanus, acellular pertussis, and inactivated poliovirus. |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Combination (4 doses) |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NCT00655148 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA
|